CCMG
Clark Capital Management Group’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.3M | Buy |
1,779,776
+214,041
| +14% | +$8.22M | 0.47% | 59 |
|
|
2025
Q1 | $60.7M | Buy |
1,565,735
+908,284
| +138% | +$35.2M | 0.43% | 69 |
|
|
2024
Q4 | $22.2M | Sell |
657,451
-623,938
| -49% | -$21.1M | 0.16% | 143 |
|
|
2024
Q3 | $52.4M | Sell |
1,281,389
-574,738
| -31% | -$23.5M | 0.36% | 85 |
|
|
2024
Q2 | $71.5M | Buy |
1,856,127
+39,072
| +2% | +$1.5M | 0.53% | 53 |
|
|
2024
Q1 | $77.9M | Buy |
1,817,055
+60,418
| +3% | +$2.59M | 0.58% | 41 |
|
|
2023
Q4 | $65.1M | Buy |
1,756,637
+679,375
| +63% | +$25.2M | 0.53% | 45 |
|
|
2023
Q3 | $39.1M | Buy |
1,077,262
+34,915
| +3% | +$1.27M | 0.39% | 78 |
|
|
2023
Q2 | $37.1M | Buy |
1,042,347
+34,353
| +3% | +$1.22M | 0.33% | 89 |
|
|
2023
Q1 | $35.9M | Buy |
1,007,994
+30,650
| +3% | +$1.09M | 0.4% | 80 |
|
|
2022
Q4 | $34.3M | Sell |
977,344
-136,181
| -12% | -$4.79M | 0.32% | 85 |
|
|
2022
Q3 | $32.8M | Buy |
1,113,525
+78,007
| +8% | +$2.3M | 0.43% | 62 |
|
|
2022
Q2 | $45.1M | Buy |
1,035,518
+49,639
| +5% | +$2.16M | 0.59% | 34 |
|
|
2022
Q1 | $42.9M | Buy |
985,879
+385,539
| +64% | +$16.8M | 0.48% | 50 |
|
|
2021
Q4 | $26.5M | Buy |
+600,340
| New | +$26.5M | 0.32% | 129 |
|
|
2016
Q3 | – | Sell |
-58,828
| Closed | -$2.55M | – | 308 |
|
|
2016
Q2 | $2.55M | Buy |
+58,828
| New | +$2.55M | 0.17% | 145 |
|
|
2014
Q3 | – | Sell |
-5,358
| Closed | -$287K | – | 317 |
|
|
2014
Q2 | $287K | Hold |
5,358
| – | – | 0.02% | 261 |
|
|
2014
Q1 | $286K | Hold |
5,358
| – | – | 0.02% | 273 |
|
|
2013
Q4 | $286K | Sell |
5,358
-138
| -3% | -$7.37K | 0.02% | 274 |
|
|
2013
Q3 | $276K | Buy |
5,496
+124
| +2% | +$6.23K | 0.02% | 289 |
|
|
2013
Q2 | $268K | Buy |
+5,372
| New | +$268K | 0.02% | 273 |
|